clomipramine has been researched along with Myoclonic Jerk in 16 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 14 cases tremor and myoclonus occurred simultaneously, and 10 patients presented at the same time tremor plus myoclonus, diaphoresis and shivering." | 6.67 | Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. ( Adès, J; Lejoyeux, M; Rouillon, F, 1993) |
| "In 14 cases tremor and myoclonus occurred simultaneously, and 10 patients presented at the same time tremor plus myoclonus, diaphoresis and shivering." | 2.67 | Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. ( Adès, J; Lejoyeux, M; Rouillon, F, 1993) |
| "This treatment produced also myoclonus and increased the time spent resting during trials." | 1.27 | Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats. ( Broitman, ST; Fóscolo, MR; Rodríguez Echandía, EL, 1983) |
| "PGE2 reduced DDT-induced myoclonus; this effect was blocked by PPP." | 1.26 | Role of prostaglandins in the antimyoclonic action of clonazepam. ( Hwang, EC; Van Woert, MH, 1981) |
| "p,p'-DDT-treated rats had increased concentrations of 5-hydroxyindoleacetic acid (5-HIAA) in seven regional areas, but serotonin was increased only in the midbrain and cerebellum." | 1.26 | p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus. ( Hwang, EC; Van Woert, MH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horga, G | 1 |
| Horga, A | 1 |
| Baeza, I | 1 |
| Castro-Fornieles, J | 1 |
| Lázaro, L | 1 |
| Pons, A | 1 |
| Rodríguez Echandía, EL | 1 |
| Broitman, ST | 1 |
| Fóscolo, MR | 1 |
| Insel, TR | 1 |
| Roy, BF | 1 |
| Cohen, RM | 1 |
| Murphy, DL | 1 |
| Hwang, EC | 2 |
| Van Woert, MH | 3 |
| Lejoyeux, M | 2 |
| Rouillon, F | 1 |
| Adès, J | 2 |
| Nijhawan, PK | 1 |
| Katz, G | 1 |
| Winter, S | 1 |
| Bloem, BR | 1 |
| Lammers, GJ | 1 |
| Roofthooft, DW | 1 |
| De Beaufort, AJ | 1 |
| Brouwer, OF | 1 |
| Rosenbaum, D | 1 |
| Tseng, LF | 1 |
| Harris, RA | 1 |
| Loh, NH | 1 |
| Fineyre, F | 1 |
| Fukuzako, H | 1 |
| Hokazono, Y | 1 |
| Tominaga, H | 1 |
| Hirakawa, K | 1 |
| Matsumoto, K | 1 |
| Lieberman, JA | 1 |
| Kane, JM | 1 |
| Reife, R | 1 |
| Casas, M | 1 |
| Garcia-Ribera, C | 1 |
| Alvarez, E | 1 |
| Udina, C | 1 |
| Queralto, JM | 1 |
| Grau, JM | 1 |
| Myers, BA | 1 |
| Klerman, GL | 1 |
| Hartmann, E | 1 |
| Marley, E | 1 |
| Wozniak, KM | 1 |
1 review available for clomipramine and Myoclonic Jerk
| Article | Year |
|---|---|
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clomipramine; Clorgyline; Depressive Disorder; Female; Humans; | 1986 |
1 trial available for clomipramine and Myoclonic Jerk
| Article | Year |
|---|---|
Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine.
Topics: Adult; Aged; Aged, 80 and over; Arousal; Brain; Clomipramine; Depressive Disorder; Female; Humans; M | 1993 |
14 other studies available for clomipramine and Myoclonic Jerk
| Article | Year |
|---|---|
Drug-induced speech dysfluency and myoclonus preceding generalized tonic-clonic seizures in an adolescent male with schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Clomipramine; Clozapine; Epilepsy, Tonic-Clonic; Humans; Male; Myo | 2010 |
Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
Topics: 5-Hydroxytryptophan; Animals; Clomipramine; Exploratory Behavior; Fluoxetine; Male; Methysergide; Mo | 1983 |
Possible development of the serotonin syndrome in man.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; My | 1982 |
Role of prostaglandins in the antimyoclonic action of clonazepam.
Topics: Animals; Benzodiazepinones; Clomipramine; Clonazepam; Indomethacin; Male; Mice; Myoclonus; Polyphlor | 1981 |
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combina | 1996 |
Clomipramine withdrawal in newborns.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Female; Humans; Infant, Newborn; Myoclonus; P | 1999 |
p,p'-DDT-induced neurotoxic syndrome: experimental myoclonus.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Clomipramine; DDT; Hydroxyindoleacetic Acid; Isomeris | 1978 |
L-5-hydroxytryptophan therapy in myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clomipramine; Double-Blind Method; Drug Eva | 1979 |
Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine.
Topics: Amphetamines; Animals; Cerebral Cortex; Chromatography, Thin Layer; Clomipramine; Conditioning, Oper | 1978 |
The serotonin syndrome.
Topics: Adult; Clomipramine; Depressive Disorder; Humans; Male; Myoclonus; Serotonin; Syndrome | 1992 |
Jerk-locked averaging and somatosensory evoked potential in tricyclic-induced myoclonus: a case report.
Topics: Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Electroencephalography; | 1989 |
Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
Topics: Adult; Aged; Clomipramine; Depression; Female; Humans; Male; Middle Aged; Myoclonus | 1987 |
Nocturnal cataclysms with myoclonus: a new side effect of clomipramine.
Topics: Clomipramine; Depressive Disorder; Female; Humans; Middle Aged; Myoclonus; Sleep Wake Disorders | 1986 |
Interactions between relatively selective monoamine oxidase inhibitors and an inhibitor of 5-hydroxytryptamine re-uptake, clomipramine.
Topics: Animals; Arrhythmias, Cardiac; Body Temperature; Cerebral Cortex; Clomipramine; Clorgyline; Drug Int | 1985 |